home / stock / bfri / bfri news


BFRI News and Press, Biofrontera Inc. From 04/01/22

Stock Information

Company Name: Biofrontera Inc.
Stock Symbol: BFRI
Market: NASDAQ
Website: biofrontera-us.com

Menu

BFRI BFRI Quote BFRI Short BFRI News BFRI Articles BFRI Message Board
Get BFRI Alerts

News, Short Squeeze, Breakout and More Instantly...

BFRI - Biofrontera Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on April 8, 2022

WOBURN, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today it will report financial results for the three months and full year ended December 31,...

BFRI - Biofrontera to Showcase Actinic Keratoses and Impetigo Treatments at the 2022 American Academy of Dermatology Annual Meeting

Company to have a strong onsite presence at the world’s l argest scientific conference for dermatologists, with approximately 10,000 medical professionals expected to attend WOBURN, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasd...

BFRI - GTE, EIGR and AQST among pre market gainers

Summer Infant (SUMR) +29% on Q4 results. Imperial Petroleum (IMPP) +19%. Mullen Automotive (MULN) +19% featured by Yahoo Finance live. Indonesia Energy (INDO) +18%. F-star Therapeutics (FSTX) +16%. Enservco (ENSV) +16%. Aquestive Therapeutics (AQST) +16% receives FDA fast track...

BFRI - Biofrontera announces FDA Orange Book listing for U.S. patent

Biofrontera (BFRI -1.9%), a biopharma company focused on dermatology, announced on Monday that its U.S. patent No. 11,235,169 for BF-RhodoLED XL is now included in the Orange Book published by the U.S. Food and Drug Administration (FDA) The publication is officially known as “Approved ...

BFRI - Biofrontera Inc. Announces FDA Orange Book Listing of U.S. Patent for BF-RhodoLED® XL, Extends Protection of Ameluz®-PDT Through October 2040

WOBURN, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI ) , a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the previously granted U.S. patent No. 11,235,169 (the ’169 pate...

BFRI - Biofrontera Inc. to Present at the 34th Annual Roth Conference

WOBURN, Mass., March 09, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, announces today that Erica Monaco, Chief Executive Officer, will be presenting a...

BFRI - Biofrontera Inc. Appoints Kevin D. Weber to its Board of Directors

WOBURN, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, announces the appointment of Kevin D. Weber to its Board of Directors, expanding...

BFRI - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! Grab a cup of coffee and get ready for the day with the biggest pre-market stock movers for Wednesday! Source: f11photo/Shutterstock.com The biggest news moving stocks this morning are earnin...

BFRI - 5 Penny Stocks To Buy Right Now According To Reddit Social Sentiment

Are penny stocks something that excites you? Are you trying to find ways to make money in the stock market today? If you said yes to either or both, continue reading. One of the most important topics of discussion since the 2020 pandemic has been social sentiment. Millions of new retail...

BFRI - IRadimed, Meridian Bioscience top healthcare gainers; Lannett, Vanda among losers

Gainers: IRadimed IRMD +8%. Meridian Bioscience VIVO +8%. Biofrontera (NASDAQ:BFRI) +6%. Inspira Technologies Oxy (NASDAQ:IINN) +6%. Taysha Gene Therapies (NASDAQ:TSHA) +5%. Losers: Lannett Company (NYSE:LCI) -24%. Vanda Pharmaceuticals (NASDAQ:VNDA) -22%. E...

Previous 10 Next 10